Stocks and InvestingStocks and Investing
Thu, April 6, 2023
Wed, April 5, 2023

Larry Biegelsen Maintained (ABT) at Buy with Decreased Target to $136 on, Apr 5th, 2023


Published on 2024-10-28 02:35:38 - WOPRAI, Larry Biegelsen
  Print publication without navigation


Larry Biegelsen of Wells Fargo, Maintained "Abbott Laboratories" (ABT) at Buy with Decreased Target from $140 to $136 on, Apr 5th, 2023.

Larry has made no other calls on ABT in the last 4 months.



There are 11 other peers that have a rating on ABT. Out of the 11 peers that are also analyzing ABT, 1 agrees with Larry's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Anthony Petrone of "Mizuho" Maintained at Hold with Increased Target to $110 on, Tuesday, January 24th, 2023


These are the ratings of the 10 analyists that currently disagree with Larry


  • Danielle Antalffy of "UBS" Initiated at Strong Buy and Held Target at $117 on, Wednesday, March 29th, 2023
  • Matt Miksic of "Barclays" Maintained at Buy with Increased Target to $125 on, Friday, January 27th, 2023
  • Lee Hambright of "Bernstein" Maintained at Buy with Increased Target to $132 on, Thursday, January 26th, 2023
  • Marie Thibault of "BTIG" Maintained at Strong Buy with Increased Target to $125 on, Thursday, January 26th, 2023
  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $123 on, Thursday, January 26th, 2023
  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $125 on, Thursday, January 26th, 2023
  • Mike Polark of "Wolfe Research" Maintained at Sell with Increased Target to $107 on, Wednesday, January 25th, 2023
  • Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Increased Target to $133 on, Friday, January 6th, 2023
  • Joshua Jennings of "TD Cowen" Maintained at Buy and Held Target at $130 on, Tuesday, December 13th, 2022
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $125 on, Monday, December 12th, 2022